Bristol-Myers says Grade 5 event in BreakFree program occurred after trial pause, aims to resume enrollment early 2027

A Bristol-Myers spokesperson said the Grade 5 event disclosed as part of data disclosure at MS Toronto occurred after the trial pause and was not related to the decision to pause the BreakFree program. The company is working closely with the FDA to restart the trial as soon as possible, aiming to resume enrollment in early 2027.

Detected & updated continuously · Source: Nebula